Key result
Severe neonatal enterovirus infection resulted in a 30.4% overall lethality rate, with the highest lethality of 38.6% observed in neonates complicated with myocarditis.
Why the study?
Neonates are at high risk of enterovirus infection with serious clinical manifestations and high lethality, necessitating systematic evidence to aid identification and treatment.
Systematic Review (n=237)
Severe neonatal enterovirus infection carries a high lethality rate of 30.4%, which rises to 38.6% when complicated by myocarditis, underscoring the need for early recognition and intensive supportive care.
Answers are grounded in this paper and cite their sources.
High lethality in severe neonatal EV, especially with myocarditis, warrants early vigilance; supports targeted surveillance while leaving optimal therapies open.
BACKGROUND: Enterovirus (EV) is a common cause of infection in neonates. Neonates are at high risk of enterovirus infection with serious clinical manifestations and high lethality. This review systematically summarized the clinical characteristics of neonates with severe enteroviral infection to provide evidence for the identification and treatment of severe neonatal EV infection. METHODS: PubMed, Embase, and Web of Science were searched for original studies on neonates with severe EV infections from January 1, 2000, to November 27, 2020. Two reviewers independently screened the literature, extracted the data, and performed a descriptive analysis. RESULTS: In total, 66 articles with 237 cases of severe neonatal enterovirus infection were included. All neonates developed severe complications. Among them, 46.0% neonates had hepatitis or coagulopathy, 37.1% had myocarditis, 11.0% had meningoencephalitis, and 5.9% had other complications such as hemophagocytic lymphohistiocytosis and pulmonary hemorrhage. The lethality rate of neonates with severe infection was 30.4%. The highest lethality rate was 38.6%, which was observed in neonates with myocarditis. In 70.5% neonates, the age at the onset of symptoms was less than 7 days. Coxsackievirus B infection was seen in 52.3% neonates. The most common symptoms included temperature abnormalities (127, 53.6%), rash (88, 37.1%), poor feeding (58, 24.5%), and respiratory symptoms (52, 21.9%). The main treatment included transfusion of empirical antibiotics (127, 53.6%), blood components (100, 42.2%), intravenous immunoglobulin (IVIG; 97, 40.9%), mechanical ventilation (51, 21.5%), and extracorporeal membrane oxygenation (ECMO; 43, 18.1%). Additionally, antiviral medications pleconaril (14, 5.9%) and pocapavir (3, 1.3%) were administered. CONCLUSIONS: Lethality was high in neonates with severe enterovirus infection, especially in those complicated with myocarditis. The most common symptoms included temperature abnormalities, rash, and poor feeding. The chief supportive treatment consisted of transfusion of blood components, mechanical ventilation, and ECMO. Empirical antibiotics and IVIG were widely used. Antiviral medications included pocapavir and pleconaril; however, more clinical evidence regarding their efficacy is needed.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) conducted a systematic review in Severe neonatal enterovirus infection (n=237). Severe enterovirus infection was evaluated on Lethality rate. Severe neonatal enterovirus infection resulted in a 30.4% overall lethality rate, with the highest lethality of 38.6% observed in neonates complicated with myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: